Characterization of Mycobacterium tuberculosis rhodanese-like sulfurtransferase SseA and its newly identified activator Rv3284: A new pathway to exploit as a drug target?
Giulia Di Napoli, Alex Fissore, Edoardo Salladini…·Mauro Marengo
This paper identifies Rv3284 (SufEMtb) as a new activator of Mtb's SseA enzyme, revealing a regulatory mechanism that could be targeted for tuberculosis therapy.